Metamfetamine
- Generic Name
- Metamfetamine
- Brand Names
- Desoxyn
- Drug Type
- Small Molecule
- Chemical Formula
- C10H15N
- CAS Number
- 537-46-2
- Unique Ingredient Identifier
- 44RAL3456C
- Background
Metamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug, and a member of the amphetamine group of sympathomimetic amines. Methamphetamine can induce effects such as euphoria, increased alertness and energy, and enhanced self-esteem. It is a scheduled drug in most countries due to its high potential for addiction and abuse.
...
- Indication
For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Refractory exogenous obesity
- Associated Therapies
- -
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
- Conditions
- Interventions
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Clear Scientific, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06721494
- Locations
- 🇺🇸
California Clinical Trials Medical Group, Glendale, California, United States
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
- Conditions
- Interventions
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Carolyn Rodriguez
- Target Recruit Count
- 40
- Registration Number
- NCT05783817
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
- Conditions
- Interventions
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 43
- Registration Number
- NCT05379959
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Brain Function and EEG
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 40
- Registration Number
- NCT05003076
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Drugs Brain and Behavior (DDP)
- Conditions
- Interventions
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 113
- Registration Number
- NCT04642820
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Mirtazapine and Methamphetamine Drug-drug Interaction Study
- Conditions
- Interventions
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- San Francisco Department of Public Health
- Target Recruit Count
- 24
- Registration Number
- NCT04614584
- Locations
- 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸San Francisco Department of Public Health, San Francisco, California, United States
🇺🇸Substance Use Research Unit, San Francisco, California, United States
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
- Conditions
- Interventions
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Craig Rush
- Target Recruit Count
- 8
- Registration Number
- NCT04178993
- Locations
- 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States
🇺🇸University of Kentucky, Lexington, Kentucky, United States
Effect of Stimulant Drugs on Social Perception
- Conditions
- Interventions
- First Posted Date
- 2018-12-31
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 36
- Registration Number
- NCT03790618
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Study of Pomaglumetad and Methamphetamine
- Conditions
- Interventions
- First Posted Date
- 2017-04-10
- Last Posted Date
- 2020-09-01
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 19
- Registration Number
- NCT03106571
- Locations
- 🇺🇸
UCLA, Santa Monica, California, United States
Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 90
- Registration Number
- NCT02323048
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.